A detailed history of Summit Financial, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Summit Financial, LLC holds 38,661 shares of JNJ stock, worth $6.42 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
38,661
Previous 23,133 67.12%
Holding current value
$6.42 Million
Previous $3.66 Million 54.41%
% of portfolio
0.26%
Previous 0.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$144.38 - $157.78 $2.24 Million - $2.45 Million
15,528 Added 67.12%
38,661 $5.65 Million
Q1 2024

Apr 24, 2024

BUY
$155.22 - $162.74 $439,117 - $460,391
2,829 Added 13.93%
23,133 $3.66 Million
Q4 2023

Feb 05, 2024

SELL
$145.6 - $158.88 $179,524 - $195,899
-1,233 Reduced 5.73%
20,304 $3.18 Million
Q3 2023

Nov 07, 2023

BUY
$155.75 - $174.48 $96,253 - $107,828
618 Added 2.95%
21,537 $3.35 Million
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $841,361 - $905,465
5,451 Added 35.24%
20,919 $3.46 Million
Q1 2023

May 03, 2023

SELL
$151.05 - $180.26 $45,163 - $53,897
-299 Reduced 1.9%
15,468 $2.4 Million
Q4 2022

Feb 07, 2023

SELL
$160.2 - $179.79 $1 Million - $1.13 Million
-6,265 Reduced 28.44%
15,767 $2.79 Million
Q3 2022

Nov 15, 2022

BUY
$161.33 - $179.52 $480,602 - $534,790
2,979 Added 15.64%
22,032 $3.6 Billion
Q2 2022

Aug 12, 2022

BUY
$168.19 - $186.01 $646,858 - $715,394
3,846 Added 25.29%
19,053 $3.38 Million
Q1 2022

May 10, 2022

BUY
$158.14 - $179.59 $448,485 - $509,317
2,836 Added 22.92%
15,207 $2.7 Million
Q4 2021

Feb 07, 2022

BUY
$155.93 - $173.01 $571,327 - $633,908
3,664 Added 42.08%
12,371 $2.12 Million
Q3 2021

Nov 08, 2021

BUY
$161.5 - $179.47 $693,158 - $770,285
4,292 Added 97.21%
8,707 $1.41 Million
Q2 2021

Aug 06, 2021

BUY
$159.48 - $171.07 $704,104 - $755,274
4,415 New
4,415 $727,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Summit Financial, LLC Portfolio

Follow Summit Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Financial, LLC with notifications on news.